Accessibility Menu
PharmaCielo logo

PharmaCielo

(OTC) PCLOF

Current Price$0.07
Market Cap$13.33M
Since IPO (2019)-99%
5 Year-94%
1 Year+73%
1 Month+17%

PharmaCielo Financials at a Glance

Market Cap

$13.33M

Revenue (TTM)

CA$2.60M

Net Income (TTM)

-CA$3.98M

EPS (TTM)

-$0.02

P/E Ratio

-3.98

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$0.07

Volume

58,000

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

Aug 14, 2026

PCLOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCielo

Industry

Pharmaceuticals

CEO

Marc Lustig, MBA

Headquarters

Toronto, ON M5C 1P1, CA

PCLOF Financials

Key Financial Metrics (TTM)

Gross Margin

29%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

25%

Return on Assets

-53%

Earnings Yield

-25.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.33M

Shares Outstanding

187.98M

Volume

58.00K

Avg. Volume

92.89K

Financials (TTM)

Gross Profit

CA$633.02K

Operating Income

-CA$3.85M

EBITDA

-CA$1.29M

Operating Cash Flow

-CA$881.18K

Capital Expenditure

CA$4.12

Free Cash Flow

-CA$881.18K

Cash & ST Invst.

CA$289.01K

Total Debt

CA$18.63M

PharmaCielo Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$605.65K

-46.3%

Gross Profit

CA$999.42K

+107.0%

Gross Margin

1.65%

N/A

Market Cap

$13.33M

N/A

Market Cap/Employee

$49.73K

N/A

Employees

268

N/A

Net Income

CA$407.08K

+127.1%

EBITDA

CA$868.43K

+305.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$289.01K

+95.4%

Total Debt

CA$18.63M

-9.2%

Accounts Receivable

CA$618.74K

+3.5%

Inventory

CA$1.72M

+14.1%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$18.63M

+17.6%

Return on Assets

-53.17%

N/A

Return on Invested Capital

24.90%

N/A

Free Cash Flow

CA$530.32K

+235.4%

Operating Cash Flow

CA$530.31K

+235.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LOBEFLobe Sciences Ltd.
$0.06-15.72%
CPIVFCaptiva Verde Wellness Corp.
$0.03-7.14%
BBRRFBlueberries Medical Corp.
$0.01+0.00%
AVTBFAvant Brands Inc.
$0.43+7.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.16-0.00%
KEELKeel Infrastructure
$6.34+0.06%
HOODRobinhood Markets
$104.59+0.08%
TAT&T
$22.51-0.03%

Questions About PCLOF

What is the current price of PharmaCielo?

PharmaCielo is trading at $0.07 per share.

What is the 52-week range for PharmaCielo?

Over the past 52 weeks, PharmaCielo has traded between $0.00 and $0.12.

How much debt does PharmaCielo have?

As of the most recent reporting period, PharmaCielo reported total debt of CA$13.60M.

How much cash does PharmaCielo have on hand?

PharmaCielo reported CA$211.01K in cash and cash equivalents in its most recent financial results.

What is PharmaCielo’s dividend yield?

PharmaCielo does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.